4//SEC Filing
Tousignant Jennifer 4
Accession 0000950170-24-015205
CIK 0001590750other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:05 PM ET
Size
5.7 KB
Accession
0000950170-24-015205
Insider Transaction Report
Form 4
Tousignant Jennifer
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-12+290,000→ 290,000 totalExercise: $19.68Exp: 2034-02-12→ Common Stock (290,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% on February 12, 2025 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0002010978
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:05 PM ET
- Size
- 5.7 KB